Morgan Stanley lowered the firm’s price target on Corebridge (CRBG) to $39 from $40 and keeps an Overweight rating on the shares. The firm said its price target changes for the Life Insurance sector reflect tailwinds from higher equity markets and headwinds related to Fed cuts.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBG:
- Corebridge price target lowered to $40 from $42 at Piper Sandler
- Corebridge Financial Reclassifies Variable Annuity Business
- Corebridge announces availability of life insurance products through Allstate
- Corebridge Financial Approves Retention Awards for Executives
- Corebridge Financial Appoints New CEO Marc Costantini